Assisted Reproduction and Ovarian Stimulation
Research activity focuses on in vitro fertilization, controlled ovarian stimulation, and treatment strategies for women with suboptimal ovarian response and advanced maternal age. The sponsor’s trials examine the balance between stimulation intensity and reproductive outcomes in patients undergoing fertility treatment.
- Ovarian stimulation optimization
- Embryo quality
- Euploid embryo yield
- Elective fertility preservation
Its research also includes progestin-primed ovarian stimulation, GnRH antagonist and GnRH agonist approaches, and personalized stimulation strategies for patients with reduced ovarian sensitivity.
Embryology and Preimplantation Genetic Testing
The sponsor supports studies centered on oocyte maturation, blastocyst development, and embryo euploidy, with particular attention to outcomes relevant to preimplantation genetic testing for aneuploidy. These trials address laboratory and clinical endpoints linked to embryo competence in fertility care.
- Metaphase II oocyte retrieval
- Blastocyst quality
- Euploid embryo production
- Embryo competence
Research in this area extends to trigger strategies for final oocyte maturation and stimulation protocols designed to improve reproductive laboratory outcomes.
Hormonal Support in Fertility Treatment
Another key area is luteal phase support and hormonal optimization during assisted reproduction. Trials examine vaginal micronized progesterone formulations, serum progesterone profiles, and the progesterone-to-estradiol ratio in women undergoing fertility treatment.
- Luteal phase support
- Progesterone supplementation
- Hormone monitoring
- Ongoing pregnancy outcomes
These studies are closely linked to frozen embryo transfer and stimulation protocols in patients with prior poor response to treatment.
Genitourinary Syndrome of Menopause
The sponsor also funds research in menopausal urogenital health, particularly the management of genitourinary syndrome of menopause. The clinical focus includes local regenerative and hormonal approaches for symptoms affecting the vaginal and genitourinary tissues.
- Local estrogen therapy
- Autologous platelet-rich plasma
- Hyaluronic acid-based treatment
- Vaginal tissue symptoms
This area reflects interest in non-surgical therapies for postmenopausal discomfort and tissue restoration.
Metabolic Factors and Reproductive Outcomes
Current studies also explore the influence of overweight and obesity on fertility treatment outcomes, including embryo quality in patients undergoing IVF. The sponsor’s research includes metabolic modulation in relation to reproductive performance.
- Metabolic status
- Embryo development
- Weight-related fertility factors
- Reproductive endocrinology
These investigations are aligned with individualized fertility care in patients whose reproductive response may be affected by metabolic profile.
